182 related articles for article (PubMed ID: 38416322)
1. Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates.
Alrahahleh D; Thoma Y; Van Daele R; Nguyen T; Halena S; Luig M; Stocker S; Kim HY; Alffenaar JW
Clin Pharmacokinet; 2024 Mar; 63(3):367-380. PubMed ID: 38416322
[TBL] [Abstract][Full Text] [Related]
2. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
3. Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients.
Cunio CB; Uster DW; Carland JE; Buscher H; Liu Z; Brett J; Stefani M; Jones GRD; Day RO; Wicha SG; Stocker SL
Clin Microbiol Infect; 2020 Jul; ():. PubMed ID: 32673799
[TBL] [Abstract][Full Text] [Related]
4. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A
Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279
[TBL] [Abstract][Full Text] [Related]
6. Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill Patients.
Kallee S; Scharf C; Schatz LM; Paal M; Vogeser M; Irlbeck M; Zander J; Zoller M; Liebchen U
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145667
[TBL] [Abstract][Full Text] [Related]
7. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
[TBL] [Abstract][Full Text] [Related]
8. Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase-negative staphylococcus.
Chung E; Seto W
Pharmacotherapy; 2023 Dec; 43(12):1262-1276. PubMed ID: 37574774
[TBL] [Abstract][Full Text] [Related]
9. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Schatz LM; Brinkmann A; Röhr A; Frey O; Greppmair S; Weinelt F; Zoller M; Scharf C; Hempel G; Liebchen U
Antimicrob Agents Chemother; 2023 May; 67(5):e0010423. PubMed ID: 37125925
[TBL] [Abstract][Full Text] [Related]
10. Bayesian forecasting of serum vancomycin concentrations in neonates and infants.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Ther Drug Monit; 1995 Jun; 17(3):239-46. PubMed ID: 7624919
[TBL] [Abstract][Full Text] [Related]
11. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.
Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT
JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set.
Hughes JH; Tong DMH; Faldasz JD; Frymoyer A; Keizer RJ
Clin Pharmacokinet; 2023 Jan; 62(1):67-76. PubMed ID: 36404388
[TBL] [Abstract][Full Text] [Related]
13. Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.
Greppmair S; Brinkmann A; Roehr A; Frey O; Hagel S; Dorn C; Marsot A; El-Haffaf I; Zoller M; Saller T; Zander J; Schatz LM; Scharf C; Briegel J; Minichmayr IK; Wicha SG; Liebchen U
Intensive Care Med; 2023 Aug; 49(8):966-976. PubMed ID: 37439872
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
Guo T; van Hest RM; Zwep LB; Roggeveen LF; Fleuren LM; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG; van Hasselt JGC
Pharm Res; 2020 Aug; 37(9):171. PubMed ID: 32830297
[TBL] [Abstract][Full Text] [Related]
15. Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates.
Tang BH; Zhang JY; Allegaert K; Hao GX; Yao BF; Leroux S; Thomson AH; Yu Z; Gao F; Zheng Y; Zhou Y; Capparelli EV; Biran V; Simon N; Meibohm B; Lo YL; Marques R; Peris JE; Lutsar I; Saito J; Jacqz-Aigrain E; van den Anker J; Wu YE; Zhao W
Clin Pharmacokinet; 2023 Aug; 62(8):1105-1116. PubMed ID: 37300630
[TBL] [Abstract][Full Text] [Related]
16. External validation of population pharmacokinetic models of vancomycin in postoperative neurosurgical patients.
Wei S; Chen J; Zhao Z; Mei S
Eur J Clin Pharmacol; 2023 Aug; 79(8):1031-1042. PubMed ID: 37261482
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.
Zhang R; Chen M; Liu TT; Lu JJ; Lv CL
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):135-149. PubMed ID: 31541402
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
Allegaert K; Flint R; Smits A
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
[No Abstract] [Full Text] [Related]
19. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
[TBL] [Abstract][Full Text] [Related]
20. Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill.
Narayan SW; Thoma Y; Drennan PG; Yejin Kim H; Alffenaar JW; Van Hal S; Patanwala AE
Crit Care Med; 2021 Oct; 49(10):e952-e960. PubMed ID: 33938713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]